FilingSEC EDGAR8-K
Arcadia Biosciences Receives Nasdaq Deficiency Notice
· SEC accepted
StageNon-compliance with listing rules
Filing content
The company's stockholders' equity fell below the $2.5 million requirement, and it must submit a compliance plan by October 15, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…